Various agonists for RTK and GPCR increase Ca2+ release from the ER via the activation of inositol 1,4,5-trisphosphate receptors (IP3Rs) in GBM cells (Kang et al., 2010). The gene discussed is ITPR1; the disease is glioblastoma.